Trial Profile
A retrospective study to investigate the efficacy of Bevacizumab in patients with choroidal-neovascularisation secondary to pathological myopia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Choroidal neovascularisation
- Focus Therapeutic Use
- 21 Dec 2015 New trial record